GSIS
ABBV icon

Global Strategic Investment Solutions’s AbbVie ABBV Stock Holding History

Global Strategic Investment Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$212K Sell
974
-1,420
-59% -$315K 0.02% 141
2025
Q4 		$547K Buy
2,394
+1
+0% +$228 0.05% 102
2025
Q3 		$554K Buy
+2,393
New +$487K 0.06% 101
2025
Q2 		– Sell
-1,102
Closed -$231K – 153
2025
Q1 		$231K Sell
1,102
-56
-5% -$10.9K 0.03% 137
2024
Q4 		$206K Sell
1,158
-141
-11% -$25.9K 0.02% 152
2024
Q3 		$257K Buy
+1,299
New +$242K 0.03% 133

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Global Strategic Investment Solutions's ABBV Position: Q1 2026 in Review

Global Strategic Investment Solutions reduced its AbbVie (ABBV) stake by 59% in Q1 2026, selling an estimated $315K and leaving 974 shares worth $212K. The position accounts for 0.02% of the portfolio, ranked #141.

Global Strategic Investment Solutions first reported a position in ABBV in Q3 2024 and has held it in 6 quarters since. The position peaked at $554K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Global Strategic Investment Solutions held 974 shares of AbbVie worth $212K as of Q1 2026.
  • Global Strategic Investment Solutions sold 1,420 AbbVie shares in Q1 2026, an estimated $315K.
  • AbbVie made up 0.02% of Global Strategic Investment Solutions's portfolio in Q1 2026, its #141 holding.
  • Global Strategic Investment Solutions first reported a position in AbbVie in Q3 2024 and has held it in 6 quarters since.
  • Global Strategic Investment Solutions's AbbVie position peaked at $554K in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Global Strategic Investment Solutions's 13F filing for Q1 2026, filed 29 Apr 2026.